The New York Times reports that some academic scientists and physicians are tired of the notation next to their names that indicates that they have accepted money from a drug, food, or medical device company. They now reject honoraria in hopes of restoring their good names. "It is not worth it to be under suspicion," says Brigham and Women's Peter Libby.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.